Document is current
Any future updates will be listed below
-
Authors
Bouchard, D. http://orcid.org/0000-0003-0984-8545
Pigot, F.
de Parades, V.
Staumont, G.
Abramowitz, L.
Siproudhis, L.
,
Bouchard, D.
Pigot, F.
de Parades, V.
Staumont, G.
Abramowitz, L.
Siproudhis, L.
Tracanelli, L.
Fathallah, N.
Babin-Pigot, E.
Ferry, M.
,
Bouguen, G.
Laharie, D.
Cotte, E.
Panis, Y.
Peyrin-Biroulet, L.
Roblin, X.
Zerbib, P.
- License Information
-
More Information
Article History
Received: 19 October 2021
Accepted: 29 July 2022
First Online: 21 August 2022
Declarations
:
: DB: Takeda as consultant, Abbvie Janssen Takeda for learning. LS: Takeda Abbvie Janssen MSD for clinical research, Takeda as consultant, Takeda Abbvie Janssen Amgen Ferring for learning. VdP: Takeda as consultant, Abbvie, Amgen, Tillots for learning. GS: Takeda, Janssen as consultant, Abbvie, Takeda for learning. LA: Abbvie, Takeda, Celltrion for clinical research, Takeda as consultant, Takeda, Abbvie, Janssen, Ferring for learning. FP: Abbvie, Takeda for learning.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.
